VX-765 Therapy, Given Through Nose, Limits MS Progression & Fighting Anxiety to Help Others With MS
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how an early study shows that VX-765 therapy, given through the nose, limits MS progression.
Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, discusses how she fought past her anxiety to create a resource to help others diagnosed with illnesses like MS, despite challenges.
=====================================
Trea...
13m
•
Nov 16, 2020